A new feature on the cholesterol-lowering landscape
Daniel J. Rader
Center for Experimental Therapeutics University of Pennsylvania School of Medicine Philadelphia, Pennsylvania, USA
rader@mail.med.upenn.edu
Reduction in blood levels of low-density lipoprotein cholesterol reduces the risk of coronary heart disease. The identification of a new class of compounds that upregulate the low-density lipoprotein receptor may lead to new therapeutic advances. (pages 1332−1338)
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
